Q1UE34 Stock Overview
Provides diagnostic testing and services in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 4/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
My Notes
Capture your thoughts, links and company narrative
Quest Diagnostics Incorporated Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$479.92 |
| 52 Week High | US$480.77 |
| 52 Week Low | US$328.82 |
| Beta | 0.91 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | 55.90% |
| 3 Year Change | 40.48% |
| 5 Year Change | 104.39% |
| Change since IPO | 108.03% |
Recent News & Updates
Recent updates
Shareholder Returns
| Q1UE34 | BR Healthcare | BR Market | |
|---|---|---|---|
| 7D | 0% | 1.0% | -1.3% |
| 1Y | 55.9% | -9.7% | -7.8% |
Return vs Industry: Q1UE34 exceeded the BR Healthcare industry which returned -9.5% over the past year.
Return vs Market: Q1UE34 exceeded the BR Market which returned -8.2% over the past year.
Price Volatility
| Q1UE34 volatility | |
|---|---|
| Q1UE34 Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.0% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in BR Market | 9.8% |
| 10% least volatile stocks in BR Market | 3.2% |
Stable Share Price: Q1UE34's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: Insufficient data to determine Q1UE34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1967 | 55,000 | Jim Davis | www.questdiagnostics.com |
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals.
Quest Diagnostics Incorporated Fundamentals Summary
| Q1UE34 fundamental statistics | |
|---|---|
| Market cap | R$108.88b |
| Earnings (TTM) | R$4.93b |
| Revenue (TTM) | R$56.25b |
22.1x
P/E Ratio1.9x
P/S RatioIs Q1UE34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| Q1UE34 income statement (TTM) | |
|---|---|
| Revenue | US$9.87b |
| Cost of Revenue | US$6.60b |
| Gross Profit | US$3.27b |
| Other Expenses | US$2.41b |
| Earnings | US$866.00m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 7.80 |
| Gross Margin | 33.15% |
| Net Profit Margin | 8.77% |
| Debt/Equity Ratio | 90.2% |
How did Q1UE34 perform over the long term?
See historical performance and comparisonDividends
1.9%
Current Dividend Yield38%
Payout RatioDoes Q1UE34 pay a reliable dividends?
See Q1UE34 dividend history and benchmarks| Quest Diagnostics dividend dates | |
|---|---|
| Ex Dividend Date | Apr 04 2025 |
| Dividend Pay Date | Apr 25 2025 |
| Days until Ex dividend | 40 days |
| Days until Dividend pay date | 61 days |
Does Q1UE34 pay a reliable dividends?
See Q1UE34 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/22 19:00 |
| End of Day Share Price | 2025/01/30 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Quest Diagnostics Incorporated is covered by 45 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jasper Hellweg | Argus Research Company |
| Brian Kemp Dolliver | Avondale Partners |
| Eric Coldwell | Baird |